IL5 and Sepsis: In addition, it is known that IL-33 is a potent activator of type 2 Innate Lymphoid Cells (ILC2), which results in enhanced production of the key effector cytokines IL-5 and IL-13, and that IL-33 plays a major role in local inflammatory changes in the lung, early after the onset of sepsis [40].